Coverage and distributional benefit–cost of rotavirus vaccine in Uganda: an analysis of routine health facility aggregated data

Table 2 Estimated coverage for rotavirus vaccine doses and DPT-3 in comparison with WHO estimates

Year	Rotavirus vaccine (dose 1)		Rotavirus vaccine (dose 2)		DTP vaccine (dose 1)**	DTP vaccine (dose 3)
Year	Adj.DHIS-2	WUENIC	Adj.DHIS-2	WUENIC***	WUENIC	Adj.DHIS-2	WUENIC
2018	58.1%	–	26.7%	36.0%	97%	88%	93.0%
2019	89.4%	–	68.2%	87.0%	96%	88%	93.0%
2020	86.5%	–	65.0%	88.0%	94%	90%	89.0%
2021	88.9%	–	64.9%	87.0%	97%	89%	91.0%

Adj.—adjusted
WUENIC WHO and UNICEF estimates of national immunization coverage
**In our study, we used the 2016 Uganda Demographic Household Survey coverage of DPT-1 (95%) and assume no changes over the years
-Estimates not available
***Percentage of surviving infants who received the final recommended dose of rotavirus vaccine, which can be either the 2nd or the 3rd dose depending on the vaccine

ISSN: 1478-7547